InvestorsHub Logo
icon url

TheDane

10/25/19 3:00 PM

#275162 RE: farrell90 #275158

The Money Quote...

"...we continue to diligently work toward completing other transactions that would unlock additional shareholder value. As such, we are thrilled to engage Locust Walk—with their proven track record and global footprint.”

“... completing other transactions...”

...implies continuing something, not starting something. “Other transactions” must already be commence. That’s how I read it.

Thanks!
icon url

JTORENCE

10/25/19 3:22 PM

#275164 RE: farrell90 #275158

farrell90 If and when. Same was said of the big "P" and how did that go??

From the 9/10/2019 PR

Arthur P. Bertolino, MD, PhD, MBA, President and Chief Medical Officer at Innovation Pharmaceuticalsstated,"If oral Brilacidin performs in UC like we believe it can, we should find ourselves in a strong negotiating position toward securing additional licensing agreements in a market that runs into the tens of billions of dollars.”